Log In
BCIQ
Print this Print this
 

NRL001

  Manage Alerts
Collapse Summary General Information
Company Norgine B.V.
DescriptionMethoxamine
Molecular Target Adrenergic receptor alpha 1 (ADRA1)
Mechanism of ActionAdrenergic receptor alpha 1 (ADRA1) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat fecal incontinence
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today